Targeting TGF-βR1 Signaling Pathway in Pancreatic Cancer: A Potential Approach with Synthetic Flavanols

Synthetic flavonols, particularly RFL-1, show promise as ALK-5 inhibitors and potential therapies for pancreatic adenocarcinoma, warranting further in vivo validation.

Authors

Institutions

Publication Details

Journal
Anti-Cancer Agents in Medicinal Chemistry
Published
2025-10-02
DOI
https://doi.org/10.2174/0118715206388963250901091741
Primary Topic
TGF-β signaling in diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting TGF-βR1 Signaling Pathway in Pancreatic Cancer: A Potential Approach with Synthetic Flavanols

Milind J. Bhitre, Rachel Cordeiro, Shivam Varma, Shubham Varma et al.
Anti-Cancer Agents in Medicinal Chemistry
TGF-β signaling in diseases
article

Targeting TGF-βR1 Signaling Pathway in Pancreatic Cancer: A Potential Approach with Synthetic Flavanols

Milind J. Bhitre, Rachel Cordeiro, Shivam Varma, Shubham Varma, Sumit Waragade
article en

Abstract

Synthetic flavonols, particularly RFL-1, show promise as ALK-5 inhibitors and potential therapies for pancreatic adenocarcinoma, warranting further in vivo validation.

Anti-Cancer Agents in Medicinal ChemistryVol. 25
Government of Maharashtra (IN), Shreemati Nathibai Damodar Thackersey Women's University (IN)
Openalex Percentile: Top 75%
TGF-β signaling in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.